Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (199)	4/24/2005 1:49:50 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 360

Upcoming scientfic conferences: 04/27/2005 - 04/28/2005 2005 FDA Science Forum Washington, DC 05/17/2005 - 05/19/2005 Bio IT World Boston, MA 05/23/2005 - 05/25/2005 CHI's Biomarker World Congress Philadelphia, PA 05/23/2005 - 05/24/2005 CBI's Predictive Human Safety & Risks Boston, MA 05/24/2005 - 05/26/2005 CHI's World Pharmaceutical Congress (Lead Optimization) Philadelphia, PA 06/06/2005 - 06/08/2005 IBC's Early Efficacy Assessment Boston, MA 06/19/2005 - 06/23/2005 Society of Toxicological Pathology (STP) Washington, DC 06/25/2005 - 06/29/2005 International Conference on Intelligent Systems for Molecular Biology (ISMB) Detroit, MI 06/25/2005 - 06/30/2005 Teratology St. Pete Beach, FL 06/26/2005 - 06/30/2005 Drug Information Association (DIA) Washington, DC 10/05/2005 - 10/07/2005 Phacilitate's Fall R&D Leaders' Forum Berlin 11/06/2005 - 11/09/2005 American College of Toxicology (ACT) Williamsburg, VA 12/03/2005 - 12/07/2005 American College of Veterinary Pathology (ACVP) Boston, MA I went to their website today to see how many investor conferences they'll be doing. Was disappointed to see them on the R&R list today--the glgc website right now does not pull up any investor conferences. Hopefully it will not be too many. I think it is not so good to hold a CC and promise a profit two years down the road, but then start issuing new shares (presumably that is precisely what the R&R conference is for). After all, they've said what they will put into Horizon (it was something like $40M over the next two years) and they have enough cash to make it, certainly if they sell of the CRO stuff (which is what I think they should do, Mr. Brink.) Brown must smell dilution--they've decreased holdings from around 3M to less than 1M shares-- SEC filing showed up friday, same day as the quarterly report. I do think it is pretty unlikely (??) they will sell shares at any discount to the current price available on Wall Street--which values the company at minus 9M. After all, they could sell the company right here right now for a higher price. You do not sell part of the company to new shareholders at a discount to liquidation value, do you? Current shareholders would sue? Of course, there is waning institutional interest apparently. Class action? I have been willing to give managment the benefit of the doubt recently, after all, I have paid well less than book value for my shares, but if there is a PIPE at $3 I think I am going to be a lot pissed off.